CAR-based cell therapies for systemic lupus erythematosus
Abstract. The remarkable efficacy of chimeric antigen receptor (CAR) T cell therapy in hematological malignancies has provided a solid basis for the therapeutic concept, wherein specific pathogenic cell populations can be eradicated by means of targeted recognition. During the past few years, CAR-ba...
Saved in:
| Main Authors: | Yiyang Wang, Liangjing Lu, Shuang Ye, Qiong Fu, Xiangxiang Pan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2025-03-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000003406 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives
by: Jincai Zhou, et al.
Published: (2024-12-01) -
GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. M. Reshetnyak, et al.
Published: (2014-07-01) -
Immunotargets and Therapy for Systemic Lupus Erythematosus
by: Mok CC
Published: (2025-06-01) -
Rituximab as the first-line treatment in newly diagnosed systemic lupus erythematosus
by: Haiting Wang, et al.
Published: (2025-06-01) -
Anti-B cell therapy in patients with systemic lupus erythematosus
by: M. E. Tsanyan, et al.
Published: (2018-01-01)